Insight Molecular Diagnostics Inc. - Common Stock (NQ:IMDX)

3.380 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insight Molecular Diagnostics Inc. - Common Stock

Transcript: Insight Molecular Q2 2026 Earnings Conference Call ↗

August 24, 2026

Insight Molecular (NASDAQ:IMDX) released second-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings...

Via Benzinga

Topics Earnings

Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript ↗

August 17, 2026

FDA review nears completion as reimbursement rates support commercial launch.

Via The Motley Fool

Topics Earnings

Oncocyte Eyes Faster, Less Invasive Heart Transplant Rejection Testing ↗

August 17, 2026

Insight Molecular Diagnostics discussed the potential use of donor-derived cell-free DNA testing in heart transplant surveillance during a virtual session featuring transplant cardiologist Dr. Max...

Via MarketBeat

Oncocyte Q2 Earnings Call Highlights ↗

August 10, 2026

Oncocyte (NASDAQ:IMDX) executives said they continue to target FDA marketing authorization for the GraftAssureDx kidney-transplant rejection test later this year, while preparing for a commercial...

Via MarketBeat

Topics Earnings

Insight Molecular Diagnostics (NASDAQ:IMDX) Soars on 285% Revenue Beat and Key FDA Submission ↗

March 26, 2026

Via Chartmill

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

Exploring Insight Molecular's Earnings Expectations ↗

August 08, 2025

Via Benzinga

IMDX Q1 2026 Earnings Call Transcript ↗

May 13, 2026

IMDX Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

These stocks are moving in today's session ↗

April 14, 2026

Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Topics Artificial Intelligence

INSIGHT MOLECULAR DIAGNOSTIC (NASDAQ:IMDX) Stock Plummets 11.8% on Q3 Earnings Miss ↗

November 10, 2025

Insight Molecular Dx (IMDX) stock fell 11.8% after missing Q3 2025 revenue and EPS estimates. The company remains focused on its FDA submission for the GraftAssureDx™ test.

Via Chartmill

A Look at Insight Molecular's Upcoming Earnings Report ↗

November 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 25, 2025

Via Benzinga

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.